當前位置：首頁 SCI期刊 SCIE期刊醫(yī)學中科院3區(qū) JCRQ2 期刊介紹(非官網(wǎng))

Blood PurificationSCIE

國際簡稱：BLOOD PURIFICAT 參考譯名：血液凈化

中科院分區(qū)
3區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q2

基本信息：: ISSN：0253-5068; E-ISSN：1421-9735; 是否OA：未開放; 是否預警：否; TOP期刊：否

出版信息：: 出版地區(qū)：SWITZERLAND; 出版商：S. Karger AG; 出版語言：English; 出版周期：Bimonthly; 出版年份：1983; 研究方向：醫(yī)學-泌尿?qū)W與腎臟學

評價信息：: 影響因子：2.2; H-index：55; CiteScore指數(shù)：5.8; SJR指數(shù)：0.782; SNIP指數(shù)：0.91

發(fā)文數(shù)據(jù)：: Gold OA文章占比：22.12%; 研究類文章占比：76.04%; 年發(fā)文量：96; 自引率：0.0333...; 開源占比：0.124; 出版撤稿占比：0; 出版國人文章占比：0.17; OA被引用占比：0.2663...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Blood Purification期刊介紹

Practical information on hemodialysis, hemofiltration, peritoneal dialysis and apheresis is featured in this journal. Recognizing the critical importance of equipment and procedures, particular emphasis has been placed on reports, drawn from a wide range of fields, describing technical advances and improvements in methodology. Papers reflect the search for cost-effective solutions which increase not only patient survival but also patient comfort and disease improvement through prevention or correction of undesirable effects. Advances in vascular access and blood anticoagulation, problems associated with exposure of blood to foreign surfaces and acute-care nephrology, including continuous therapies, also receive attention. Nephrologists, internists, intensivists and hospital staff involved in dialysis, apheresis and immunoadsorption for acute and chronic solid organ failure will find this journal useful and informative. 'Blood Purification' also serves as a platform for multidisciplinary experiences involving nephrologists, cardiologists and critical care physicians in order to expand the level of interaction between different disciplines and specialities.

期刊簡介Blood Purification期刊介紹

《Blood Purification》自1983出版以來，是一本醫(yī)學優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學研究結(jié)果，并為醫(yī)學各個領域的原創(chuàng)研究提供一個展示平臺，以促進醫(yī)學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€重要領域的所有重要發(fā)展。該期刊特色在于及時報道醫(yī)學領域的最新進展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間：較慢,6-12周
醫(yī)學
HEMATOLOGY
SCIE
中科院3區(qū)
非預警

Cite Score數(shù)據(jù)（2024年最新版）Blood Purification Cite Score數(shù)據(jù)

CiteScore：5.8
SJR：0.782
SNIP：0.91

學科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Nephrology	Q1	15 / 81	82%
大類：Medicine 小類：Hematology	Q2	40 / 137	71%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Blood Purification 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區(qū)	小類學科	分區(qū)
醫(yī)學	3區(qū)	HEMATOLOGY 血液學 UROLOGY & NEPHROLOGY 泌尿?qū)W與腎臟學	4區(qū) 4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎，運用科學計量學方法對國際、國內(nèi)學術期刊依據(jù)影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構(gòu)的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機構(gòu)的廣泛認可。

中科院分區(qū)表 將所有期刊按照一定指標劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次，類似于“優(yōu)、良、及格”等。最開始，這個分區(qū)只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學術期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Blood Purification JCR分區(qū)

2023-2024 年最新版

按JIF指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：HEMATOLOGY	SCIE	Q3	53 / 97	45.9%
學科：UROLOGY & NEPHROLOGY	SCIE	Q2	54 / 126	57.5%

按JCI指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：HEMATOLOGY	SCIE	Q2	32 / 97	67.53%
學科：UROLOGY & NEPHROLOGY	SCIE	Q2	48 / 126	62.3%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學術文獻質(zhì)量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計

國家/地區(qū)數(shù)量
CHINA MAINLAND85
Italy80
USA63
Japan44
Netherlands24
France22
GERMANY (FED REP GER)17
Brazil14
Spain11
Australia10

本刊中國學者近年發(fā)表論文

1、Prolonged Intermittent Renal Replacement Therapy Combined with Hemoperfusion Can Improve Early Recovery of Moderate and Severe Acute Pancreatitis, Especially in Patients with Acute Kidney Injury
Author: Gong, Meiling; Pan, Hao; Yang, Xi; Pan, Chunyu; Ning, Yong; Li, Junhua

Journal: BLOOD PURIFICATION. 2023; Vol. 52, Issue 1, pp. 75-85. DOI: 10.1159/000525230
2、Efficacy and Safety of a Low-Flow Extracorporeal Carbon Dioxide Removal System in Acute Respiratory Failure, a Pilot Study in China
Author: Zhang, Ruhan; Tian, Chao; Cai, Shuhan; Ma, Jing; Li, Jin; Li, Zhaoyang; You, Jinkun; Ding, Xinbo; Peng, Zhiyong

Journal: BLOOD PURIFICATION. 2023; Vol. 52, Issue 2, pp. 132-139. DOI: 10.1159/000525867
3、Risk Factors and Prognosis of Acute Kidney Injury after Cardiac Surgery in Patients with Chronic Kidney Disease
Author: Zhang, Dong; Teng, Jie; Luo, Zhe; Ding, Xiaoqiang; Jiang, Wuhua

Journal: BLOOD PURIFICATION. 2023; Vol. 52, Issue 2, pp. 166-173. DOI: 10.1159/000526120
4、Extracorporeal Carbon Dioxide Removal in Patients with Acute Respiratory Distress Syndrome or Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
Author: Zhu, Yu; Zhen, Weifeng; Zhang, Xiaoning; Shi, Zhenhua; Zhang, Ling; Zhou, Jiuju; Meng, Xiangzhong

Journal: BLOOD PURIFICATION. 2023; Vol. 52, Issue 2, pp. 103-113. DOI: 10.1159/000525983
5、Role of Hemodialysis in Acute Severe Alcohol Intoxication: A Meta-Analysis
Author: Zeng, Siyao; Ma, Lei; Yang, Lishan; Hu, Xiaodong; Wang, Cheng; Guo, Xinxin; Li, Yi; Gou, Yi

Journal: BLOOD PURIFICATION. 2023; Vol. 52, Issue 3, pp. 296-308. DOI: 10.1159/000527622
6、Clinical Outcomes of Prolonged Antiplatelet Therapy after Percutaneous Coronary Intervention in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis
Author: Zhang, Jialing; Li, Han; Wang, Shixiang

Journal: BLOOD PURIFICATION. 2023; Vol. 52, Issue 3, pp. 255-263. DOI: 10.1159/000527566
7、Recent Understanding and Future Directions in the Application of MMP-2 in Encapsulating Peritoneal Sclerosis Clinical Practice
Author: Fang, Yaxuan; Chen, Xin; Zhong, Ke; Ni, Qingying; He, Zhenyang; Qiao, Yanheng; Zhao, Yanru; Li, Jie; Yang, Hongtao; Yang, Bo

Journal: BLOOD PURIFICATION. 2023; Vol. 52, Issue 4, pp. 359-365. DOI: 10.1159/000528001
8、Higher Serum Magnesium Is a Survival Advantage in Maintenance Hemodialysis Patients
Author: Yu, Ling; Zu, Yuan; Lu, Jian; Li, Han; Wang, Shixiang

Journal: BLOOD PURIFICATION. 2023; Vol. 52, Issue 4, pp. 382-391. DOI: 10.1159/000528383